0000950123-24-011486.txt : 20241114
0000950123-24-011486.hdr.sgml : 20241114
20241114075657
ACCESSION NUMBER: 0000950123-24-011486
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240930
FILED AS OF DATE: 20241114
DATE AS OF CHANGE: 20241114
EFFECTIVENESS DATE: 20241114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Fund Management, LLC
CENTRAL INDEX KEY: 0001637359
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16844
FILM NUMBER: 241457259
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: Omega Fund Management (US) Inc.
DATE OF NAME CHANGE: 20150320
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001637359
XXXXXXXX
09-30-2024
09-30-2024
false
Omega Fund Management, LLC
888 Boylston St., Suite 1111
Boston
MA
02199
13F HOLDINGS REPORT
028-16844
N
Alexia Pearsall
Chief Financial Officer, Omega Fund Management, LLC
617.921.2117
/s/ Alexia Pearsall
Boston
MA
11-14-2024
0
11
160008732
false
INFORMATION TABLE
2
37113.xml
INFORMATION TABLE FOR FORM 13F
Alumis Inc
Common Stock
022307102
6976422
653223
SH
SOLE
653223
0
0
Bicara Therapeutics Inc.
Common Stock
055477103
56152436
2204650
SH
SOLE
2204650
0
0
enGene Holdings Inc.
Common Stock
29286M105
7103956
1076357
SH
SOLE
1076357
0
0
enGene Holdings Inc.
Warrant
29286M113
675154
321502
SH
SOLE
321502
0
0
Ikena Oncology
Common Stock
45175G108
3890983
2249123
SH
SOLE
2249123
0
0
Immunic Inc
Common Stock
4525EP101
2950464
1788160
SH
SOLE
1788160
0
0
Lexeo Therapeutics
Common Stock
52886X107
21297372
2355904
SH
SOLE
2355904
0
0
Nuvation Bio
Common Stock Class A
67080N101
29935659
13072340
SH
SOLE
13072340
0
0
Replimune Group
Common Stock
76029N106
26976056
2461319
SH
SOLE
2461319
0
0
Sana Biotechnology, Inc.
Common Stock
799566104
3510000
843750
SH
SOLE
843750
0
0
Syros Pharmaceuticals
Common Stock
87184Q206
540231
251270
SH
SOLE
251270
0
0